Cancer stem cells, cornerstone of radioresistance and perspectives for radiosensitization: Glioblastoma as an example;Facteurs de radiorésistance des cellules souches cancéreuses et perspectives de radiosensibilisation: L'Exemple du glioblastome

Bulletin du Cancer

Volumn 99, Issue 12, 2012, Pages 1153-1160

  Chargari, Cyrus ^a,b   Moncharmont, Coralie ^c,d   Lévy, Antonin ^b   Guy, Jean Baptiste ^c   Bertrand, Gérald ^d   Guilbert, Matthieu ^e   Rousseau, Claire ^a   Védrine, Lionel ^a   Alphonse, Gersende ^d   Toillon, Robert Alain ^e   Rodriguez Lafrasse, Claire ^d   Deutsch, Éric ^a,b   Magné, Nicolas ^c,d  

^a University of Paris Descartes   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c INSTITUT DE CANCÉROLOGIE LUCIEN NEUWIRTH   (France)

^d UNIVERSITÉ LYON 1   (France)

^e UNIV LILLE   (France)

Author keywords

Cancer stem cells; Hypoxia; Radiation therapy; Radioresistance

Indexed keywords

RADIOSENSITIZING AGENT;

CANCER RADIOTHERAPY; CANCER STEM CELL; DRUG TARGETING; GLIOBLASTOMA; HUMAN; RADIOSENSITIVITY; RADIOSENSITIZATION; REVIEW;

EID: 84872287973     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2012.1666     Document Type: Article

References (61)

1. Schatton T, Frank NY, Frank MH. Identification and targeting of cancer stem cells. Bioessays 2009; 10 : 1038-49.
2. Hill RP, Milas L. The proportion of stem cells in murine tumours. Int J Radiat Oncol Biol Phys 1989; 16 : 513-8. (Pubitemid 19077222)
3. Barker N, Ridgway RA, van Es JH, et al. Crypts stem cells as the cells-of-origin of intestinal cancer. Nature 2009; 457 : 608-11.
4. Zhu L, Gibson P, Currle DS, et al. Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature 2009; 45 : 603-7.
5. Alcantara Llaguno S, Chen J, Kwon CH, et al. Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. Cancer Cell 2009; 15 : 45-56.
6. Mani SA, Guo W, Liao MJ, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 13 : 704-15. (Pubitemid 351636299)
7. Polyak K,Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 2009; 9 : 265-73.
8. Chaffer CL, Brueckmann I, Scheel C, et al. Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc Natl Acad Sci U S A 2011; 108 : 7950-5.
9. Pajonk F, Vlashi E, McBride WH. Radiation resistance of cancer stem cells: the 4 R's of radiobiology revisited. Stem Cells 2010; 28 : 639-48.
10. Mils L, Hittelman WN. Cancer stem cells and tumour response to therapy: current problems and future prospects. Semin Radiat Oncol 2009; 19 : 96-105.
11. Baumann M, Krause M, Hill R. Exploring the role of cancer stem cells in radioresistance. Nat Rev Cancer 2008; 8 : 545-54. (Pubitemid 351881850)
12. Bao S, Wu Q, McLendon RE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006; 444 : 756-60. (Pubitemid 44949604)
13. Phillips TM, McBride WH, Pajonk F. The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst 2006; 98 : 1777-85. (Pubitemid 46017929)
14. Kim RK, Yoon CH, Hyun KH, et al. Role of lymphocyte-specific protein tyrosine kinase (LCK) in the expansion of glioma-initiating cells by fractionated radiation. Biochem Biophys Res Commun 2010; 402 : 631-6.
15. Pawlik TM, Keyomarsi K. Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys 2004; 59 : 928-42. (Pubitemid 38834285)
16. Wilson A, Laurenti E, Oser G, et al. Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell 2008; 135 : 1118-29.
17. Fan X, Matsui W, Khaki L, et al. Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. Cancer Res 2006; 66 : 7445-52. (Pubitemid 44289197)
18. Wang J, Wakeman TP, Lathia JD, et al. Notch promotes radioresistance of glioma stem cells. Stem Cells 2010; 28 : 17-28.
19. Rich JN. Cancer stem cells in radiation resistance. Cancer Res 2007; 67 : 8980-4. (Pubitemid 47535877)
20. Cheng L, Bao S, Rich JN. Potential therapeutic implications of cancer stem cells in glioblastoma. Biochem Pharmacol 2010; 80 : 654-65.
21. Cao R, Tsukada Y, Zhang Y. Role of BMI-1 and Ring1A in H2A ubiquitylation and Hox gene silencing. Mol Cell 2005; 20 : 845-54. (Pubitemid 41814874)
22. Facchino S, Abdouh M, Chatoo W, et al. BMI confers radioresistance to normal and cancerous neural stem cells through recruitment of the DNA damage response machinery. J Neurosci 2010; 30 : 10096-111.
23. Cheng L, Wu Q, Huang Z, et al. L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1. EMBO J 2011; 30 : 800-13.
24. Sarcar B, Kahali S, Prabhu AH, et al. Targeting radiation-induced G(2) checkpoint activation with the Wee-1 inhibitor MK-1775 in glioblastoma cell lines. Mol Cancer Ther 2011; 10 : 2405-14.
25. Jamal M, Rath BH, Tsang PS, et al. The brain microenvironment preferentially enhances the radioresistance of CD133(+) glioblastoma stem-like cells. Neoplasia 2012; 14 : 150-8.
26. Bao S,Wu Q, Sathornsumetee S, et al. Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res 2006; 66 : 7843-8. (Pubitemid 44299144)
27. Calabrese C, Poppleton H, Kocak M, et al. A perivascular niche for brain tumor stem cells. Cancer Cell 2007; 11 : 69-82. (Pubitemid 46054518)
28. Diehn M, Cho RW, Lobo NA, et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 2009; 458 : 780-3.
29. Li Z, Bao S,Wu Q, et al. Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell 2009; 15 : 501-13.
30. McCord AM, Jamal M, Shankavarum UT, et al. Physiologic oxygen concentration enhances the stem-like properties of CD133+ human glioblastoma cells in vitro. Mol Cancer Res 2009; 7 : 489-97.
31. Moncharmont C, Levy A, Gilormini M, et al. Targeting a cornerstone of radiation resistance: cancer stem cell. Cancer Lett 2012; 322 : 139-47.
32. Rich JN, Eyler CE. Cancer stem cells in brain tumor biology. Cold Spring Harb Symp Quant Biol 2008; 73 : 411-20.
33. Bar EE, Chaudhry A, Lin A, et al. Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma. Stem Cells 2007; 25 : 2524-33. (Pubitemid 47582744)
34. Clement V, Sanchez P, de Tribolet N, et al. HEDGEHOGGLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr Biol 2007; 17 : 165-72.
35. Lee J, Son MJ,Woolard K, et al. Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-iniating cells. Cancer Cell 2008; 13 : 69-80. (Pubitemid 350309742)
36. Piccirillo SG, Reynolds BA, Zanetti N, et al. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 2006; 444 : 761-5. (Pubitemid 44949605)
37. Soeda A, Inagaki A, Oka N, et al. Epidermal growth factor plays a crucial role in mitogenic regulation of human brain tumor stem cells. J Biol Chem 2008; 283 : 10958-66.
38. Ma HI, Chiou SH, Hueng DY, et al. Celecoxib and radioresistant glioblastoma-derived CD133+ cells: improvement in radiotherapeutic effects. Laboratory investigation. J Neurosurg 2011; 114 : 651-62.
39. Chang CJ, Chiang CH, Song WS, et al. Inhibition of phosphorylated STAT3 by cucurbitacin I enhances chemoradiosensitivity in medulloblastoma-derived cancer stem cells. Childs Nerv Syst 2012; 28 : 363-73.
40. Yang YP, Chang YL, Huang PI, et al. Resveratrol suppresses tumorigenicity and enhances radiosensitivity in primary glioblastoma tumor initiating cells by inhibiting the STAT3 axis. J Cell Physiol 2012; 227 : 976-93.
41. Zhang M, Kleber S, Röhrich M, et al. Blockade of TGF-β signaling by the TGFßR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma. Cancer Res 2011; 71 : 7155-67.
42. Günther HS, Schmidt NO, Phillips HS, et al. Glioblastoma-derived stem cell-enriched cultures from distinct subgroups according to molecular and phenotypic criteria. Oncogene 2008; 27 : 2897-9.
43. Joo KM, Jin J, Kim E, et al. MET signaling regulates glioblastoma stem cells. Cancer Res 2012; 72 : 3828-38.
44. Ellsworth R, Welsh J, Mahadevan D, et al. The radiosensitizing effects of a novel tyrosine kinase inhibitor, Mp470 in glioblastoma multiforme stem cells. Int J Radiat Oncol Biol Phys 2008; 72 : 714-5.
45. Paglin S, Hollister T, Delohery T, et al. A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Res 2001; 61 : 439-44. (Pubitemid 32128593)
46. Abedin MJ, Wang D, McDonnell MA, et al. Autophagy delays apoptotic death in breast cancer cells following DNA damage. Cell Death Differ 2007; 14 : 500-10.
47. Zhuang W, Li B, Long L, et al. Knockdown of the DNA-dependent protein kinase catalytic subunit radiosensitizes glioma-initiating cells by inducing autophagy. Brain Res 2011 : 13717-815.
48. Lomonaco SL, Finniss S, Xiang C, et al. Cilengitide induces autophagy-mediated cell death in glioma cells. Neuro Oncol 2011; 13 : 857-65.
49. Kang KB, Zhu C, Wong YL, et al. Gefitinib radiosensitizes stem-like glioma cells: inhibition of epidermal growth factor receptor-Akt- DNA-PK signaling, accompanied by inhibition ofDNA double-strand break repair. Int J Radiat Oncol Biol Phys 2012; 83 : 43-52.
50. Hambardzumyan D, Becher OJ, Rosenblum MK, et al. PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo. Genes Dev 2008; 22 : 436-48. (Pubitemid 351272752)
51. Li L, Dutra A, Pak E, et al. EGFRvIII expression and PTEN loss synergistically induce chromosomal instability and glial tumors. Neuro Oncol 2009; 11 : 9-21.
52. Ayyanan A, Civenni G, Ciarloni L, et al. Increased Wnt signaling triggers oncogenic conversion of human breast epithelial cells by a Notch-dependent mechanism. Proc Natl Acad Sci U S A 2006; 103 : 3799-804. (Pubitemid 43376635)
53. Polakis P. Wnt signaling and cancer. Genes Dev 2000; 14 : 1837-51. (Pubitemid 30639518)
54. Kendziorra E, Ahlborn K, Spitzner M, et al. Silencing of the Wnt transcription factor TCF4 sensitizes colorectal cancer cells to (chemo-) radiotherapy. Carcinogenesis 2011; 32 : 1824-31.
55. Huang FT, Zhuan-Sun YX, Zhuang YY, et al. Inhibition of hedgehog signaling depresses self-renewal of pancreatic cancer stem cells and reverses chemoresistance. Int J Oncol 2012; 4 : 1707-14.
56. Santini R, Vinci MC, Pandolfi S, et al. HEDGEHOG-GLI signaling drives self-renewal and tumorigenicity of human melanoma-initiating cells. Stem Cells 2012; 30 : 1808-18.
57. Hsieh A, Ellsworth R, Hsieh D. Hedgehog/GLI1 regulates IGF dependent malignant behaviors in glioma stem cells. J Cell Physiol 2011; 226 : 1118-27.
58. Chang JY, Zhang X, Vassiliev O, et al. Proton therapy targets cancer stem cells in treatment-resistant non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2010; 78 : 644.
59. Cui X, Oonishi K, Tsujii H, et al. Effects of carbon ion beam on putative colon cancer stem cells and its comparison with X-rays. Cancer Res 2011; 71 : 3676-87.
60. Gupta T, Nair V, Paul SN, et al. Can irradiation of potential cancer stem-cell niche in the subventricular zone influence survival in patients with newly diagnosed glioblastoma? J Neurooncol 2012; 109 : 195-203.
61. Vlashi E, Kim K, Dealla DL, et al. In-vivo imaging, tracking, and targeting of cancer stem cells. J Natl Cancer Inst 2009; 101 : 350-9.